Review: Steroid avoidance or withdrawal does not increase mortality or graft loss in kidney transplant patients

Nosrati, Mordechai Saeid; Pascual, J.
September 2009
ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p8
Academic Journal
The article presents the findings of a study regarding the efficacy and safety of steroid avoidance in kidney transplant recipients. The research evaluated steroid avoidance or withdrawal, with one group randomized to steroid avoidance or withdrawal after more than two weeks of treatment in patients receiving a kidney transplant. The study revealed that steroid avoidance or withdrawal increases risk for acute graft rejection but does not increase mortality.


Related Articles

  • Severe Early Rejection Predicts Graft Outcome.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p32 

    Assesses the impact on graft survival of rejection episodes (RE) during the first year post renal transplantation. Long-term graft survival rates; Lack of effect of benign RE during the first year after transplant on long-term kidney graft outcome.

  • The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Timm H. Westhoff; Sven Schmidt; Petra Glander; Lutz Liefeld; Sebastian Martini; Gerd Offermann; Hans H. Neumayer; Walter Zidek; Markus van der Giet; Klemens Budde // Nephrology Dialysis Transplantation;Aug2007, Vol. 22 Issue 8, p2354 

    Background. FTY720 has recently demonstrated a similar efficacy in prevention of acute graft rejection compared with mycophenolate mofetil (MMF) in a large phase III trial of de novo renal transplant recipients. Creatinine clearance, however, was significantly lower in FTY720-treated patients....

  • The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection. Dragun, Duska // Pediatric Nephrology;Jul2007, Vol. 22 Issue 7, p911 

    Acute rejection with vascular involvement remains a challenging problem in renal allotransplantation. Fibrinoid necrosis of the arteries with secondary thrombotic occlusions is C4d negative in 50% of cases and has the worst prognosis among all allograft vascular lesions. Nonhuman leukocyte...

  • FNAB by Flow Cytometry: A Rapid, Safe Diagnostic Tool.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p31 

    Tests the hypothesis that fine-needle aspiration biopsy samples in conjunction with peripheral blood lymphocyte analysis by flow cytometry more reliably diagnosed acute rejection in kidney transplant patients. Observed differences from several lymphocyte subpopulations on FNAB; Obtained values...

  • Pretransplant Cell-Mediated Lympholysis Correlates with Chronic Rejection/Graft Failure.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p31 

    Assesses whether cell-mediated cytotoxicity (CML) predicted chronic rejection in kidney transplantation. Prevalence rate of chronic rejection; Association between pretransplant cytotoxic T-lymphocyte activity and chronic rejection and graft failure in halpoidentical pediatric patients.

  • Molecular immunology and immunopharmacology of allograft rejection. Strom, Terry B. // Kidney International Supplement;Oct1992, Issue 38, pS-182 

    Discusses molecular immunology and pharmacology in the treatment of kidney transplant engraftment. Mechanism of T-cell activation in non-presensitized individual graft rejection; Effects of immunosuppressive agents in T-cells of patient with allograft; Significance of the understanding the...

  • Antilymphocyte globulins in kidney transplantation. Kreis, Henri // Kidney International Supplement;Oct1992, Issue 38, pS-188 

    Discusses the efficacy of anti-lymphocyte polyclonal globulins (ALG) in kidney transplantation. Application of the polyclonal globulin as a therapy for patient with acute rejection episodes; Advantages of utilizing ALG; Effects of anti-CD3 antibodies on the treatment of allograft rejection.

  • Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study. Zapf, Antonia; Gwinner, Wilfried; Karch, Annika; Metzger, Jochen; Haller, Hermann; Koch, Armin // BMC Nephrology;9/16/2015, Vol. 16 Issue 1, p1 

    Background: Reliable and timely detection of acute rejection in renal transplant patients is important to preserve the allograft function and to prevent premature allograft failure. The current gold standard for the rejection diagnosis is an allograft biopsy which is usually...

  • Rejecting rejection. ROGERS, DIANE // Stanford Medicine;May2010, p6 

    The article offers the case study of a 29 year old woman who had a successful kidney transplant. She had her first four-hour infusion of a desensitization drug, intravenous immunoglobulin which was designed to lower the number of organ-rejecting antibodies in patients. It mentions that she still...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics